CardioRenal Systems Secures FDA IDE Approval and Strategic Hospital Investment
FDA approves Investigational Device Exemption (IDE) for pivotal study and investment from St. Elizabeth Healthcare advances RenalPro™ toward the U.S. market. MILFORD, MA, UNITED STATES, July 7, 2026 /EINPresswire.com/ -- CardioRenal Systems, a …